Improved guidelines will optimize efficacy and minimize adverse effects of biosimilar drugs

Author: Adis International Limited  

Publisher: Adis International

ISSN: 1172-0360

Source: Drugs & Therapy Perspectives, Vol.24, Iss.8, 2008-08, pp. : 24-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract